Clinical Trial: Efficacy of Dry Needling in Plantar Fasciitis
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Efficacy of Dry Needling in Plantar Fasciitis
Brief Summary: The plantar fasciitis (PF) is the most common cause of pain on the underside of the heel. About 10% to 20% of the population suffer once during their lifetime. PF concept began to describe at the end of XX century through the discovery of new clinical and histopathological signs of the plantar fascia. The difficulty of diagnosis, understanding and treatment of PF require us to develop new treatment avenues to improve the approach and the understanding of it. Dry needling (DN) as a treatment of myofascial pain syndrome (MPS) and myofascial trigger points (MTP) of muscle associated with the pathology, it may be a good treatment strategy, as demonstrated in the treatment of MPS in other body regions such as the neck, shoulder or the lumbar spine.
Detailed Summary:
Hypothesis:
Add dry needling to a physiotherapy intervention, increases the efficacy of treatment for plantar fasciosis.
Objectives:
General:
Test the efficacy of DN in addition to physiotherapy treatment includes: manual therapy and home exercises; directed to normalize muscle tone and inhibit MTP of the gastrocnemius and soleus muscles, in a group of patients who have been diagnosed with PF.
The variables to measure the efficacy are:
Pain assessment in the affected heel, by visual analog scale (VAS). Ultrasonographic assessment of the thickness of the plantar fascia affected, in longitudinal view, compared with the contralateral.
Goniometric assessment of joint range of ankle dorsiflexion, compared with the contralateral.
Specific:
Analyze the efficacy of the combination of DN treatment with manual therapy and home exercise, in patients who have been diagnosed with PF through monitoring and comparison between groups.
Methodology:
Type of study: clinical trial.
Sample:
It has been used sample size calculator GRANMO version 7.12, and accepting an alpha risk of 0.05 and a beta risk of 0.2, 15 subjects were required in the first group and 15 in the second to detect a difference equal to or greater than 0.6 units. It is assumed that the common standard deviation is 0.57. It has been est
Sponsor: Universidad Complutense de Madrid
Current Primary Outcome: Ultrasonographic evaluation of the thickness of the affected plantar fascia, in longitudinal view. [ Time Frame: 6 months. ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Pain assessment in the affected heel, by visual analog scale. [ Time Frame: 6 months. ]
- Goniometric assessment of joint range of motion ankle dorsiflexion. [ Time Frame: 6 months. ]
Original Secondary Outcome: Same as current
Information By: Universidad Complutense de Madrid
Dates:
Date Received: May 27, 2015
Date Started: May 2014
Date Completion: October 2017
Last Updated: June 9, 2015
Last Verified: June 2015
